UKTN
The University of Southampton and biopharma company UCB have launched the Digital Antibody Research Collaboration (DARC) to develop an end-to-end platform for the in-silico design of therapeutic antibodies. In-silico refers to research, modelling or experiments conducted solely on a computer or via simulation. DARC seeks to rapidly develop, implement, test and apply cutting-edge technologies to […] The post University of Southampton and UCB to develop digital antibodies with AI appeared first on UKTN .
Go to News Site